|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | |
| A61P 1/04 | |||
| A61P 11/00 | |||
| A61P 11/06 | |||
| A61P 17/00 | |||
| A61P 17/06 | |||
| A61P 19/02 | |||
| A61P 29/00 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| A61P 37/00 | |||
| A61P 37/02 | |||
| A61P 37/06 | |||
| A61P 37/08 |
| (11) | Number of the document | 3092253 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15735107.3 |
| Date of filing the European patent application | 2015-01-09 | |
| (97) | Date of publication of the European application | 2016-11-16 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/010785 |
| Date | 2015-01-09 |
| (87) | Number | WO 2015/106080 |
| Date | 2015-07-16 |
| (30) | Number | Date | Country code |
| 201461925946 P | 2014-01-10 | US |
| (72) |
HORLICK, Robert A., US
KING, David J., US
MCKNIGHT, Andrew John, US
|
| (73) |
AnaptysBio, Inc.,
10421 Pacific Center Court, San Diego, CA 92121,
US
|
| (54) | ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33) |
| ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33) |